Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Rotavirus Vaccines Market Growth 2022-2028

  • LP 4743977
  • 90 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Rotavirus Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Rotavirus Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rotavirus Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Rotavirus Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rotavirus Vaccines market, reaching US$ million by the year 2028. As for the Europe Rotavirus Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Rotavirus Vaccines players cover Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, and Lanzhou Institute of Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Adult

Pediatric

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bharat Biotech

Merck & Co., Inc

GlaxoSmithKline plc

Lanzhou Institute of Biological

Bharat Biotech International Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rotavirus Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Rotavirus Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Rotavirus Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Rotavirus Vaccines Segment by Type

2.2.1 Rotarix

2.2.2 RotaTeq

2.2.3 Rotavac

2.2.4 Rotavin-M1

2.2.5 Lanzhou lamb

2.2.6 Others

2.3 Rotavirus Vaccines Sales by Type

2.3.1 Global Rotavirus Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Rotavirus Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Rotavirus Vaccines Sale Price by Type (2017-2022)

2.4 Rotavirus Vaccines Segment by Application

2.4.1 Adult

2.4.2 Pediatric

2.5 Rotavirus Vaccines Sales by Application

2.5.1 Global Rotavirus Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Rotavirus Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Rotavirus Vaccines Sale Price by Application (2017-2022)

3 Global Rotavirus Vaccines by Company

3.1 Global Rotavirus Vaccines Breakdown Data by Company

3.1.1 Global Rotavirus Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Rotavirus Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Rotavirus Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Rotavirus Vaccines Revenue by Company (2020-2022)

3.2.2 Global Rotavirus Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Rotavirus Vaccines Sale Price by Company

3.4 Key Manufacturers Rotavirus Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Rotavirus Vaccines Product Location Distribution

3.4.2 Players Rotavirus Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Rotavirus Vaccines by Geographic Region

4.1 World Historic Rotavirus Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Rotavirus Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Rotavirus Vaccines Annual Revenue by Geographic Region

4.2 World Historic Rotavirus Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Rotavirus Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Rotavirus Vaccines Annual Revenue by Country/Region

4.3 Americas Rotavirus Vaccines Sales Growth

4.4 APAC Rotavirus Vaccines Sales Growth

4.5 Europe Rotavirus Vaccines Sales Growth

4.6 Middle East & Africa Rotavirus Vaccines Sales Growth

5 Americas

5.1 Americas Rotavirus Vaccines Sales by Country

5.1.1 Americas Rotavirus Vaccines Sales by Country (2017-2022)

5.1.2 Americas Rotavirus Vaccines Revenue by Country (2017-2022)

5.2 Americas Rotavirus Vaccines Sales by Type

5.3 Americas Rotavirus Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rotavirus Vaccines Sales by Region

6.1.1 APAC Rotavirus Vaccines Sales by Region (2017-2022)

6.1.2 APAC Rotavirus Vaccines Revenue by Region (2017-2022)

6.2 APAC Rotavirus Vaccines Sales by Type

6.3 APAC Rotavirus Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Rotavirus Vaccines by Country

7.1.1 Europe Rotavirus Vaccines Sales by Country (2017-2022)

7.1.2 Europe Rotavirus Vaccines Revenue by Country (2017-2022)

7.2 Europe Rotavirus Vaccines Sales by Type

7.3 Europe Rotavirus Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rotavirus Vaccines by Country

8.1.1 Middle East & Africa Rotavirus Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Rotavirus Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Rotavirus Vaccines Sales by Type

8.3 Middle East & Africa Rotavirus Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccines

10.3 Manufacturing Process Analysis of Rotavirus Vaccines

10.4 Industry Chain Structure of Rotavirus Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Rotavirus Vaccines Distributors

11.3 Rotavirus Vaccines Customer

12 World Forecast Review for Rotavirus Vaccines by Geographic Region

12.1 Global Rotavirus Vaccines Market Size Forecast by Region

12.1.1 Global Rotavirus Vaccines Forecast by Region (2023-2028)

12.1.2 Global Rotavirus Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Rotavirus Vaccines Forecast by Type

12.7 Global Rotavirus Vaccines Forecast by Application

13 Key Players Analysis

13.1 Bharat Biotech

13.1.1 Bharat Biotech Company Information

13.1.2 Bharat Biotech Rotavirus Vaccines Product Offered

13.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bharat Biotech Main Business Overview

13.1.5 Bharat Biotech Latest Developments

13.2 Merck & Co., Inc

13.2.1 Merck & Co., Inc Company Information

13.2.2 Merck & Co., Inc Rotavirus Vaccines Product Offered

13.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck & Co., Inc Main Business Overview

13.2.5 Merck & Co., Inc Latest Developments

13.3 GlaxoSmithKline plc

13.3.1 GlaxoSmithKline plc Company Information

13.3.2 GlaxoSmithKline plc Rotavirus Vaccines Product Offered

13.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline plc Main Business Overview

13.3.5 GlaxoSmithKline plc Latest Developments

13.4 Lanzhou Institute of Biological

13.4.1 Lanzhou Institute of Biological Company Information

13.4.2 Lanzhou Institute of Biological Rotavirus Vaccines Product Offered

13.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lanzhou Institute of Biological Main Business Overview

13.4.5 Lanzhou Institute of Biological Latest Developments

13.5 Bharat Biotech International Limited

13.5.1 Bharat Biotech International Limited Company Information

13.5.2 Bharat Biotech International Limited Rotavirus Vaccines Product Offered

13.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bharat Biotech International Limited Main Business Overview

13.5.5 Bharat Biotech International Limited Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Rotavirus Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Rotavirus Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rotarix

Table 4. Major Players of RotaTeq

Table 5. Major Players of Rotavac

Table 6. Major Players of Rotavin-M1

Table 7. Major Players of Lanzhou lamb

Table 8. Major Players of Others

Table 9. Global Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)

Table 10. Global Rotavirus Vaccines Sales Market Share by Type (2017-2022)

Table 11. Global Rotavirus Vaccines Revenue by Type (2017-2022) & ($ million)

Table 12. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2022)

Table 13. Global Rotavirus Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)

Table 15. Global Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Table 16. Global Rotavirus Vaccines Revenue by Application (2017-2022)

Table 17. Global Rotavirus Vaccines Revenue Market Share by Application (2017-2022)

Table 18. Global Rotavirus Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Rotavirus Vaccines Sales by Company (2020-2022) & (K Units)

Table 20. Global Rotavirus Vaccines Sales Market Share by Company (2020-2022)

Table 21. Global Rotavirus Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Rotavirus Vaccines Revenue Market Share by Company (2020-2022)

Table 23. Global Rotavirus Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Rotavirus Vaccines Producing Area Distribution and Sales Area

Table 25. Players Rotavirus Vaccines Products Offered

Table 26. Rotavirus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Rotavirus Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Rotavirus Vaccines Sales Market Share Geographic Region (2017-2022)

Table 31. Global Rotavirus Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Rotavirus Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Rotavirus Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Rotavirus Vaccines Sales Market Share by Country/Region (2017-2022)

Table 35. Global Rotavirus Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Rotavirus Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)

Table 38. Americas Rotavirus Vaccines Sales Market Share by Country (2017-2022)

Table 39. Americas Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Rotavirus Vaccines Revenue Market Share by Country (2017-2022)

Table 41. Americas Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)

Table 42. Americas Rotavirus Vaccines Sales Market Share by Type (2017-2022)

Table 43. Americas Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)

Table 44. Americas Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Table 45. APAC Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)

Table 46. APAC Rotavirus Vaccines Sales Market Share by Region (2017-2022)

Table 47. APAC Rotavirus Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Rotavirus Vaccines Revenue Market Share by Region (2017-2022)

Table 49. APAC Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)

Table 50. APAC Rotavirus Vaccines Sales Market Share by Type (2017-2022)

Table 51. APAC Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)

Table 52. APAC Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Table 53. Europe Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)

Table 54. Europe Rotavirus Vaccines Sales Market Share by Country (2017-2022)

Table 55. Europe Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Rotavirus Vaccines Revenue Market Share by Country (2017-2022)

Table 57. Europe Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)

Table 58. Europe Rotavirus Vaccines Sales Market Share by Type (2017-2022)

Table 59. Europe Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)

Table 60. Europe Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Rotavirus Vaccines Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Rotavirus Vaccines

Table 70. Key Market Challenges & Risks of Rotavirus Vaccines

Table 71. Key Industry Trends of Rotavirus Vaccines

Table 72. Rotavirus Vaccines Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Rotavirus Vaccines Distributors List

Table 75. Rotavirus Vaccines Customer List

Table 76. Global Rotavirus Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Rotavirus Vaccines Sales Market Forecast by Region

Table 78. Global Rotavirus Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Rotavirus Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Rotavirus Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Rotavirus Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Rotavirus Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Rotavirus Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Rotavirus Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Rotavirus Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Rotavirus Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Rotavirus Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Rotavirus Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Rotavirus Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 96. Bharat Biotech Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 97. Bharat Biotech Rotavirus Vaccines Product Offered

Table 98. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Bharat Biotech Main Business

Table 100. Bharat Biotech Latest Developments

Table 101. Merck & Co., Inc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 102. Merck & Co., Inc Rotavirus Vaccines Product Offered

Table 103. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Merck & Co., Inc Main Business

Table 105. Merck & Co., Inc Latest Developments

Table 106. GlaxoSmithKline plc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 107. GlaxoSmithKline plc Rotavirus Vaccines Product Offered

Table 108. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. GlaxoSmithKline plc Main Business

Table 110. GlaxoSmithKline plc Latest Developments

Table 111. Lanzhou Institute of Biological Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 112. Lanzhou Institute of Biological Rotavirus Vaccines Product Offered

Table 113. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Lanzhou Institute of Biological Main Business

Table 115. Lanzhou Institute of Biological Latest Developments

Table 116. Bharat Biotech International Limited Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 117. Bharat Biotech International Limited Rotavirus Vaccines Product Offered

Table 118. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. Bharat Biotech International Limited Main Business

Table 120. Bharat Biotech International Limited Latest Developments

List of Figures

Figure 1. Picture of Rotavirus Vaccines

Figure 2. Rotavirus Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Rotavirus Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Rotavirus Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Rotavirus Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rotarix

Figure 10. Product Picture of RotaTeq

Figure 11. Product Picture of Rotavac

Figure 12. Product Picture of Rotavin-M1

Figure 13. Product Picture of Lanzhou lamb

Figure 14. Product Picture of Others

Figure 15. Global Rotavirus Vaccines Sales Market Share by Type in 2021

Figure 16. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2022)

Figure 17. Rotavirus Vaccines Consumed in Adult

Figure 18. Global Rotavirus Vaccines Market: Adult (2017-2022) & (K Units)

Figure 19. Rotavirus Vaccines Consumed in Pediatric

Figure 20. Global Rotavirus Vaccines Market: Pediatric (2017-2022) & (K Units)

Figure 21. Global Rotavirus Vaccines Sales Market Share by Application (2017-2022)

Figure 22. Global Rotavirus Vaccines Revenue Market Share by Application in 2021

Figure 23. Rotavirus Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Rotavirus Vaccines Revenue Market Share by Company in 2021

Figure 25. Global Rotavirus Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Rotavirus Vaccines Revenue Market Share by Geographic Region in 2021

Figure 27. Global Rotavirus Vaccines Sales Market Share by Region (2017-2022)

Figure 28. Global Rotavirus Vaccines Revenue Market Share by Country/Region in 2021

Figure 29. Americas Rotavirus Vaccines Sales 2017-2022 (K Units)

Figure 30. Americas Rotavirus Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. APAC Rotavirus Vaccines Sales 2017-2022 (K Units)

Figure 32. APAC Rotavirus Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Europe Rotavirus Vaccines Sales 2017-2022 (K Units)

Figure 34. Europe Rotavirus Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Rotavirus Vaccines Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Rotavirus Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Americas Rotavirus Vaccines Sales Market Share by Country in 2021

Figure 38. Americas Rotavirus Vaccines Revenue Market Share by Country in 2021

Figure 39. United States Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Rotavirus Vaccines Sales Market Share by Region in 2021

Figure 44. APAC Rotavirus Vaccines Revenue Market Share by Regions in 2021

Figure 45. China Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Rotavirus Vaccines Sales Market Share by Country in 2021

Figure 52. Europe Rotavirus Vaccines Revenue Market Share by Country in 2021

Figure 53. Germany Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country in 2021

Figure 60. Egypt Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2021

Figure 66. Manufacturing Process Analysis of Rotavirus Vaccines

Figure 67. Industry Chain Structure of Rotavirus Vaccines

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390